(Q42265420)

19 October 2017

Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice (English)

1 reference

19 October 2017

Saccharomyces cerevisiae

1 reference

Cheng-Feng Qin

10

0 references

Yong-Qiang Deng

4

object named as

Yong-Qiang Deng

1 reference

19 October 2017

Hui Zhao

1

1 reference

19 October 2017

Hao-Yang Li

2

1 reference

19 October 2017

Jian-Feng Han

3

1 reference

19 October 2017

Yue-Xiang Li

5

1 reference

19 October 2017

Shun-Ya Zhu

6

1 reference

19 October 2017

Ya-Ling He

7

1 reference

19 October 2017

E-De Qin

8

1 reference

19 October 2017

Rong Chen

9

1 reference

19 October 2017

language of work or name

English

0 references

publication date

2 October 2013

1 reference

Applied Microbiology and Biotechnology

19 October 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 October 2017

97

1 reference

19 October 2017

24

1 reference

19 October 2017

10445-10452

1 reference

https://scigraph.springernature.com/pub.10.1007/s00253-013-5257-3

19 October 2017

0 references

cites work

Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Immunological and biochemical characterization of coxsackie virus A16 viral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Assembly of human severe acute respiratory syndrome coronavirus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Progress on the research and development of inactivated EV71 whole-virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Enterovirus 71 outbreaks, Taiwan: occurrence and recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Epidemiology of hand, foot, and mouth disease and genotype characterization of Enterovirus 71 in Jiangsu, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

A neonatal mouse model of coxsackievirus A16 for vaccine evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Epidemiology and etiological characteristics of hand, foot and mouth disease in Huizhou City between 2008 and 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Virus-like particles in vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Virology, epidemiology, pathogenesis, and control of enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

FATAL COXSACKIEVIRUS A16 INFECTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Fatal infection in an infant associated with Coxsackie virus group A, type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5257-3

10.1007/S00253-013-5257-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

19 October 2017

0 references

1 reference